The lupus Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lupus Hub cannot guarantee the accuracy of translated content. The lupus and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lupus Hub is an independent medical education platform, supported through a grant from AstraZeneca. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lupus content recommended for you
Visual abstract | Tacrolimus versus IV cyclophosphamide in patients with lupus nephritis
Lupus nephritis (LN) is a common issue that patients with systemic lupus erythematosus (SLE) develop, with up to 60% of patients developing this sequela.1 For patients with SLE, LN development is associated with a significant level of morbidity and mortality; therefore, there is an urgent need to identify treatment combinations that combat this.1
A recent publication by Zheng et al.1 in Rheumatology investigated the effect of tacrolimus against intravenous cyclophosphamide in Chinese patients with LN. The Lupus Hub is happy to provide a visual abstract summarizing the data from this study.
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content